Olfactory Deficits Predict Cognitive Improvement on Donepezil in Patients With Depression and Cognitive Impairment: A Randomized Controlled Pilot Study.

about

Change in Odor Identification Impairment is Associated with Improvement with Cholinesterase Inhibitor Treatment in Mild Cognitive Impairment.

P2860

Q47231236-3257EA97-7554-4700-B0A5-89CB5468BE60

P2860

Olfactory Deficits Predict Cognitive Improvement on Donepezil in Patients With Depression and Cognitive Impairment: A Randomized Controlled Pilot Study.

Item

http://www.wikidata.org/entity/Q36609643

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Olfactory Deficits Predict Cog ...... omized Controlled Pilot Study.

@en

type

Item

label

Olfactory Deficits Predict Cog ...... omized Controlled Pilot Study.

@en

prefLabel

Olfactory Deficits Predict Cog ...... omized Controlled Pilot Study.

@en

P1476

Olfactory Deficits Predict Cog ...... omized Controlled Pilot Study.

@en

P2093

Davangere P Devanand

http://www.w3.org/2001/XMLSchema#string

Gregory H Pelton

http://www.w3.org/2001/XMLSchema#string

Laili Soleimani

http://www.w3.org/2001/XMLSchema#string

Matthias H Tabert

http://www.w3.org/2001/XMLSchema#string

Steven P Roose

http://www.w3.org/2001/XMLSchema#string

P2860

Maintenance treatment of depression in old age: a randomized, double-blind, placebo-controlled evaluation of the efficacy and safety of donepezil combined with antidepressant pharmacotherapy

A 10-item smell identification scale related to risk for Alzheimer's disease.

An olfactory 'stress test' may detect preclinical Alzheimer's disease

Randomized double-blind placebo-controlled donepezil augmentation in antidepressant-treated elderly patients with depression and cognitive impairment: a pilot study.

Influences of age and sex on a microencapsulated odor memory test.

Olfaction in neurodegenerative disease: a meta-analysis of olfactory functioning in Alzheimer's and Parkinson's diseases.

Smell identification test as a treatment response marker in patients with Alzheimer disease receiving donepezil.

Smell identification function as a severity and progression marker in Alzheimer's disease.

Depressed mood and the incidence of Alzheimer's disease in the elderly living in the community.

Development of the University of Pennsylvania Smell Identification Test: a standardized microencapsulated test of olfactory function.

P304

67-69

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/WAD.0000000000000107

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-09-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26398910

http://www.w3.org/2001/XMLSchema#string

P932

4764438

http://www.w3.org/2001/XMLSchema#string

Olfactory Deficits Predict Cognitive Improvement on Donepezil in Patients With Depression and Cognitive Impairment: A Randomized Controlled Pilot Study.

about

P2860

P2860

Olfactory Deficits Predict Cognitive Improvement on Donepezil in Patients With Depression and Cognitive Impairment: A Randomized Controlled Pilot Study.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932